BSE Live
Oct 16, 16:01Prev. Close
1671.10
Open Price
1672.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 16, 15:45Prev. Close
1670.00
Open Price
1665.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1702.10 (50)
Profit & Loss account of Epigral (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 2,514.40 | 1,893.83 | 2,169.44 | 1,549.73 | 825.94 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 2,514.40 | 1,893.83 | 2,169.44 | 1,549.73 | 825.94 | |
Total Operating Revenues | 2,550.13 | 1,929.19 | 2,188.40 | 1,550.94 | 828.60 | |
Other Income | 15.21 | 6.57 | 7.98 | 4.11 | 2.19 | |
Total Revenue | 2,565.34 | 1,935.76 | 2,196.38 | 1,555.05 | 830.79 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 1,322.40 | 1,071.60 | 1,211.76 | 759.41 | 386.10 | |
Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.42 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FGWIP And Stock In Trade | 31.09 | -10.78 | -96.97 | 1.68 | -1.20 | |
Employee Benefit Expenses | 114.48 | 89.65 | 86.60 | 76.79 | 53.61 | |
Finance Costs | 53.27 | 73.49 | 65.50 | 44.27 | 29.11 | |
Depreciation And Amortisation Expenses | 132.56 | 123.56 | 108.95 | 85.91 | 73.54 | |
Other Expenses | 371.44 | 297.51 | 298.07 | 203.57 | 128.35 | |
Total Expenses | 2,025.24 | 1,645.03 | 1,673.91 | 1,171.63 | 669.93 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 540.10 | 290.72 | 522.48 | 383.42 | 160.86 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 540.10 | 290.72 | 522.48 | 383.42 | 160.86 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 98.17 | 52.71 | 94.31 | 69.67 | 28.17 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | -18.37 | 0.00 | |
Deferred Tax | 85.23 | 42.17 | 74.86 | 42.59 | 31.85 | |
Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 183.40 | 94.88 | 169.17 | 130.64 | 60.02 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 356.70 | 195.84 | 353.31 | 252.79 | 100.84 | |
Profit/Loss From Continuing Operations | 356.70 | 195.84 | 353.31 | 252.79 | 100.84 | |
Profit/Loss For The Period | 356.70 | 195.84 | 353.31 | 252.79 | 100.84 | |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Consolidated Profit/Loss After MI And Associates | 357.69 | 195.87 | 353.29 | 252.79 | 100.84 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 85.00 | 47.00 | 85.00 | 61.00 | 24.00 | |
Diluted EPS (Rs.) | 85.00 | 47.00 | 85.00 | 61.00 | 24.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 31.56 | 10.39 | 10.39 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
05.08.2025
Epigral Consolidated June 2025 Net Sales at Rs 606.54 crore, down 6.86% Y-o-Y
05.08.2025
Epigral Standalone June 2025 Net Sales at Rs 606.54 crore, down 6.86% Y-o-Y
06.05.2025
Epigral Standalone March 2025 Net Sales at Rs 627.63 crore, up 19.63% Y-o-Y
06.05.2025
Epigral Consolidated March 2025 Net Sales at Rs 627.63 crore, up 19.63% Y-o-Y